• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑腱黄瘤病伴或不伴帕金森病患者的临床特征和神经影像学表现。

Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings.

机构信息

Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Mov Disord. 2010 Mar 15;25(4):452-8. doi: 10.1002/mds.22979.

DOI:10.1002/mds.22979
PMID:20108380
Abstract

Parkinsonism in cerebrotendinous xanthomatosis (CTX) is rare. There are no published studies with imaging findings of dopamine transporter using (99m)Tc-[2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo [3,2,1] oct-2-yl] methyl] (2-mercaptoethyl) amino] ethyl] amino]-ethanethiolato(3-)-N2,N2,S2,S2]oxo-[1R-(exo-exo)] ((99m)Tc-TRODAT-1) SPECT in CTX patients. This report is on the clinical details of five genetically-proven CTX patients (two with and three without parkinsonism). Imaging findings using cranial magnetic resonance (MR) imaging and (99m)Tc-TRODAT-1 SPECT are also shown. Clinical correlation of neuroimaging findings and clinical presentations was made. A literature review of the clinical and neuroimaging features of eight CTX patients with parkinsonism reported in the English literature is also presented. The parkinsonian features of our two cases and the other eight reported cases occurred before the age of 50 years. The MR imaging study showed variable findings, in which, besides the common diffuse cerebral and cerebellar white matter lesions shown in CTX, several focal brain lesions were also noted. Of the focal lesions, substantia nigra abnormalities were seen only in the two cases with parkinsonism. The (99m)Tc-TRODAT-1 SPECT study showed different degrees of unilateral or bilateral abnormalities in the striatal binding in both visual and semiquantitative assessments. parkinsonism can be one of the neurologic presentations of CTX. Even though abnormal findings of the substantia nigra were detected in both of our CTX patients with parkinsonism, basal ganglion lesions have not been uniformly described in MR imaging findings of reported CTX patients with parkinsonism. (99m)Tc-TRODAT-1 SPECT study can be of value in the detection of striatal involvement, and the study results also suggest pre-synaptic dopamine neuron involvement in CTX patients with parkinsonism.

摘要

脑腱黄瘤病(CTX)中帕金森病罕见。目前尚无使用(99m)Tc-[2-[[2-[[[3-(4-氯苯基)-8-甲基-8-氮杂双环[3.2.1]辛-2-基]甲基](2-巯基乙基)氨基]乙基]氨基]乙硫醇ato(3-)-N2,N2,S2,S2]氧-[1R-(外消旋外消旋)]((99m)Tc-TRODAT-1)SPECT 成像在 CTX 患者中的研究。本报告介绍了五例经基因证实的 CTX 患者(2 例伴帕金森病,3 例不伴帕金森病)的临床详细资料。还显示了使用颅磁共振成像(MR)和(99m)Tc-TRODAT-1 SPECT 的成像结果。对神经影像学发现与临床表现进行了临床相关性分析。还对英语文献中报道的 8 例伴帕金森病的 CTX 患者的临床和神经影像学特征进行了文献复习。我们的 2 例病例和其他 8 例报道的病例的帕金森病特征发生在 50 岁之前。MR 成像研究显示了不同的发现,除了 CTX 中常见的弥漫性脑和小脑白质病变外,还观察到几个局灶性脑病变。在局灶性病变中,只有 2 例伴帕金森病的患者出现黑质异常。(99m)Tc-TRODAT-1 SPECT 研究显示,在视觉和半定量评估中,纹状体结合在单侧或双侧均有不同程度的异常。帕金森病可能是 CTX 的神经表现之一。尽管我们的 2 例伴帕金森病的 CTX 患者均检测到黑质异常,但基底节病变在报道的伴帕金森病的 CTX 患者的 MR 成像结果中并未得到一致描述。(99m)Tc-TRODAT-1 SPECT 研究可用于检测纹状体受累,研究结果还提示 CTX 伴帕金森病患者的多巴胺神经元节前受累。

相似文献

1
Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings.脑腱黄瘤病伴或不伴帕金森病患者的临床特征和神经影像学表现。
Mov Disord. 2010 Mar 15;25(4):452-8. doi: 10.1002/mds.22979.
2
Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.99mTc-TRODAT-1单光子发射计算机断层显像(SPECT)成像在鉴别特发性帕金森病患者与健康受试者中的敏感性和特异性
J Nucl Med. 2004 Mar;45(3):393-401.
3
99mTc-TRODAT-1 imaging of multiple system atrophy.99m锝- TRODAT - 1对多系统萎缩的显像
J Nucl Med. 2004 Jan;45(1):49-55.
4
Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.帕金森病患者中(99m)Tc - TRODAT - 1单光子发射计算机断层扫描(SPECT)与(18)F - FDOPA正电子发射断层扫描(PET)的交叉研究
J Nucl Med. 2003 Jul;44(7):999-1005.
5
Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging.99mTc 和 123I 双同位素脑纹状体体层摄影术同时成像:99mTc-TRODAT-1 和 123I-IBZM 同时进行多巴胺能系统脑显像的验证。
Kaohsiung J Med Sci. 2009 Nov;25(11):601-7. doi: 10.1016/S1607-551X(09)70563-7.
6
Cerebrotendinous xanthomatosis presenting with asymmetric parkinsonism: a case with I-123-FP-CIT SPECT imaging.脑腱黄瘤病以不对称性帕金森病为表现:伴有 I-123-FP-CIT SPECT 成像的病例。
Acta Neurol Belg. 2012 Sep;112(3):287-9. doi: 10.1007/s13760-012-0064-7. Epub 2012 Apr 17.
7
Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.无症状的Machado-Joseph病基因携带者的多巴胺转运体浓度降低。
J Nucl Med. 2002 Feb;43(2):153-9.
8
Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.99mTc-TRODAT-1显像对早期帕金森病的评估
J Nucl Med. 2001 Sep;42(9):1303-8.
9
[2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-]oxo-[1R-exo-exo)])- [Tc]-technetium[2[[2-[[[3-(4-氯苯基)-8-甲基-8-氮杂双环[3,2,1]辛-2-基]甲基](2-巯基乙基)氨基]乙基]氨基]乙硫醇根(3-)]氧代-[1R-外向-外向)]-[锝99m]锝
10
Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.用(99m)Tc - TRODAT - 1对帕金森病和血管性帕金森综合征进行鉴别诊断。
J Nucl Med. 2001 Mar;42(3):408-13.

引用本文的文献

1
Systematic Review of Parkinsonism in Cerebrotendinous Xanthomatosis.脑腱黄瘤病中帕金森综合征的系统评价
Neurol Int. 2025 Jul 30;17(8):117. doi: 10.3390/neurolint17080117.
2
Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase.胆甾烷醇通过激活天冬酰胺内肽酶加速α-突触核蛋白聚集和扩散。
JCI Insight. 2023 Nov 8;8(21):e165841. doi: 10.1172/jci.insight.165841.
3
Using fiber tractography and diffusion kurtosis imaging to evaluate neuroimaging changes in patients with cerebrotendinous xanthomatosis after stopping chenodeoxycholic acid treatment for three years.
采用纤维束示踪和弥散峰度成像技术评估三年停用地昔泊芬酸治疗后脑腱黄瘤病患者的神经影像学变化。
Biomed J. 2022 Oct;45(5):814-820. doi: 10.1016/j.bj.2021.09.003. Epub 2021 Sep 20.
4
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.脑腱性黄瘤病:分子发病机制、临床谱、诊断和疾病修饰治疗。
J Atheroscler Thromb. 2021 Sep 1;28(9):905-925. doi: 10.5551/jat.RV17055. Epub 2021 May 8.
5
A Treatable Rare Cause of Progressive Ataxia and Palatal Tremor.一种可治疗的进行性共济失调和腭震颤的罕见病因。
Tremor Other Hyperkinet Mov (N Y). 2018 May 17;8:538. doi: 10.7916/D8X07Q2N. eCollection 2018.
6
Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.脑腱黄瘤病的神经学异常的自然病史。
J Inherit Metab Dis. 2018 Jul;41(4):647-656. doi: 10.1007/s10545-018-0152-9. Epub 2018 Feb 26.
7
Ataxia.共济失调
Neurol Clin. 2015 Feb;33(1):225-48. doi: 10.1016/j.ncl.2014.09.004.
8
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.脑腱黄瘤病:发病机制、临床表现、诊断及治疗的全面综述
Orphanet J Rare Dis. 2014 Nov 26;9:179. doi: 10.1186/s13023-014-0179-4.
9
A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis.脑腱性黄瘤病早期诊断与治疗的疑似指数
J Inherit Metab Dis. 2014 May;37(3):421-9. doi: 10.1007/s10545-013-9674-3. Epub 2014 Jan 18.
10
The neuropsychiatry of inborn errors of metabolism.先天性代谢错误的神经精神病学。
J Inherit Metab Dis. 2013 Jul;36(4):687-702. doi: 10.1007/s10545-013-9618-y. Epub 2013 May 23.